Patients with severe COVID-19 pneumonia treated with leukotriene inhibitors are more likely to survive
University at Buffalo biomedical informatics researchers have found that patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the ...
May 25, 2022
0
64